Bob Maluso

Bob Maluso is an accomplished leader in the radiopharmaceutical and healthcare sectors, currently serving as Head of PET Manufacturing Facility (PMF) Strategy at Lantheus since July 2023. Prior to this role, Bob was the Global Vice President of Theranostics and Diagnostic Imaging at GenesisCare, where responsibilities included the development and implementation of global services related to diagnostic imaging and cancer theranostics. Bob's extensive experience encompasses leadership positions at Dina as Chief Growth Officer, Prognos as Vice President of Sales and Business Development, Siemens-PETNET Solutions as Head of Global Radiopharmaceutical Business Development, and Cardinal Health NPS as President/CEO of Radiopharmacy Expansion. Educational qualifications include a Bachelor of Science in Pharmacy from The Ohio State University and an MBA in Healthcare Economics from Marylhurst University.